Dr. Abud Bakri

So that's like your first 50 years of your life.

That's what you have to expect.

The question has been, and it's a big debate in the medical community, is replacing growth hormone and addressing somatopause useful?

Because you can measure if we had your IGF-1 when you're 18 and your IGF-1 when you're 30 and 50, that's going to be a dramatic decrease in that.

Should we now replenish this IGF-1?

The proponents will say IGF-1 is important for skin.

and good quality sleep and for muscle recovery and joints and all these things.

And those are true.

We know growth hormone has all these beneficial effects on that.

We also know growth hormone is thymoregenerative because it stimulates the regrowth of an aged, involuted thymus gland based on Dr. Fahey's work.

The question is, is there an oncogenic signal when it comes to growth hormone?

Does it cause cancer?

Yes.

It's not mutagenic.

This is the big debate when people are like, BPC causes cancer.

There's no mutagenic effect.

Is BPC like smoking a cigarette?

Smoking a cigarette, you get carcinogenic damage to the lung tissue that causes a cancer later on.

There's no direct mechanism that would link any of these peptides to a carcinogenic effect.

But is it a growth factor that could grow cancer?